Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-047459
Filing Date
2018-07-26
Accepted
2018-07-26 17:25:47
Documents
1
Period of Report
2018-07-24

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4053
  Complete submission text file 0001104659-18-047459.txt   5375
Mailing Address C/O BIOVEX GROUP, INC. 34 COMMERCE WAY WOBURN MA 10801
Business Address
Astley-Sparke Philip (Reporting) CIK: 0001376491 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38596 | Film No.: 18972588

Mailing Address 18 COMMERCE WAY WOBURN MA 01801
Business Address 18 COMMERCE WAY WOBURN MA 01801 781-995-2443
Replimune Group, Inc. (Issuer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)